First Trust Direct Indexing’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
First Trust Direct Indexing's RGEN Position: Q3 2022 in Review
First Trust Direct Indexing sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,569 shares — an estimated $255K sold.
First Trust Direct Indexing first reported a position in RGEN in Q4 2020 and held it in 7 quarters. The position peaked at $293K in Q1 2022. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.
- First Trust Direct Indexing reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
- First Trust Direct Indexing sold 1,569 Repligen shares in Q3 2022, an estimated $255K.
- First Trust Direct Indexing first reported a position in Repligen in Q4 2020 and held it in 7 quarters.
- First Trust Direct Indexing's Repligen position peaked at $293K in Q1 2022.
- 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.
Based on First Trust Direct Indexing's 13F filing for Q3 2022, filed 27 Oct 2022.